Breast Cancer Research & Drug Development

Southwestern Vermont Health Care's Medical Matters Weekly

Season 2 | Episode 40 | October 5, 2022
Dr. Vahdat is the section chief of Medical Oncology and the interim section chief of Hematology at Dartmouth Cancer Center and a professor of medicine at the Geisel School of Medicine at Dartmouth. She earned her medical degree at Mount Sinai School of Medicine and completed an internal medicine residency at Mount Sinai Hospital, both in New York City. She completed a fellowship in Hematology/Oncology at Memorial Sloan-Kettering Cancer Center in New York City.
A translational breast cancer medical oncologist, Dr. Vahdat’s expertise is in drug development. She has been involved in the identification, conceptualization, design, and conduct of clinical trials of new therapies in high-risk, adjuvant, and metastatic breast cancer patients since 1994. She has led four separate drug development efforts that lead to FDA approval of three drugs active in metastatic breast cancer.

Medical Matters Weekly features the innovative personalities who drive positive change within health care and related professions. The show addresses all aspects of creating and maintaining a healthy lifestyle for all, including food and nutrition, housing, diversity and inclusion, groundbreaking medical care, exercise, mental health, the environment, research, and government. The show is produced with cooperation from Catamount Access Television (CAT-TV). Viewers can see Medical Matters Weekly on Facebook at facebook.com/svmedicalcenter and facebook.com/CATTVBennington. The show is also available to view or download a podcast on www.svhealthcare.org/medicalmatters. Questions can be emailed to [e-mail].
Underwriter: Mack Molding